Overview
Research has led to major advances in mental health care over the last century. This session will discuss the importance of research awareness for all clinicians, which was highlighted during the covid pandemic. Without the involvement of non-academic clinicians the landmark recovery trial would not have been possible. Despite this there is a common perception that research is something only for career academic clinicians.
The session will then move to the benefits for trusts of having a research portfolio and research active clinicians. The last speaker, who is the new chief executive of the British Neuroscience Association will talk about credibility in neuroscience, which includes reproducibility and generalisability.
Objectives
- Gain an awareness of how psychiatrists in consultant or SAS posts, as well as trainees, could become more involved in clinical research in psychiatry.
- Understand the importance of research for ultimately leading to improvements in patient care.
- Understand why research matters to trusts.
- Understand why poor quality science which fails replication can affect individuals and wider society and why the reproducibility crisis needs addressing.
- Understand the major factors involved in creating good quality neuroscience and why credibility matters.
Speakers
Chair: Dr Hugo Critchley, Brighton and Sussex Medical School, Brighton
Dr Trudi Seneviratne, Registrar, Royal College of Psychiatrists, London
Dr Derek Tracy, West London Mental Health Trust, King's College London, Imperial College London, London
Dr Laura Ajram, British Neuroscience Association, Bristol
